Open original FDA record ↗Recall record
- FDA identifier
- Z-2081-2026
- Company in FDA record
- BioFire Diagnostics, LLC
- FDA classification date
- May 6, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Respiratory/sore throat panel test may result in false negative results and control failures.
Source facts
- Action
- On April 1, 2026, Biomerieux, issued a "Urgent Medical Device Recall" via E-Mail. Biomerieux ask consignees to take the following actions: In this context, we request that you take the following actions: " Examine your inventory for the lot identified in this recall notice. "Discontinue use and discard any remaining product from this lot in your possession. "Please confirm the quantity of kits that have been destroyed, previously used, or returned on the attached Acknowledgement of Receipt Form. "If you have further distributed this product, please identify any recipients and notify them at once. " Please complete the accompanying Acknowledgement of Receipt Form and return to bioMrieux.
- Initiated
- 2026-04-01
- Root cause
- Under Investigation by firm
- Distribution
- US Nationwide distribution in the states of MS, TX MN, VA.
- Recall number
- Z-2081-2026
- Recall status
- Open, Classified
- CDRH record ID
- 219560
- FDA classified
- 2026-05-06
- Recall event number
- 98719